Save the Date!

Wednesday, May 4, 2022 is MACEP's Annual Meeting

CSL Behring




CONTACT INFORMATION

Sophia Andoscia
Area Manager
Sophia.Andoscia@cslbehring.com

COMPANY INFORMATION

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. We meet patients’ needs using the latest technologies to develop and deliver innovative biotherapies that are used to treat serious and rare conditions, such as coagulation disorders, primary immune deficiencies, hereditary angioedema and respiratory disease.


PRODUCT INFORMATION

Combining Capabilities to Serve More Patients with Rare Diseases
Kcentra® Information

Highlighlights of Prescribing Information

Kcentra® Clinical Practice Guidelines

Kcentra®- the only FDA-approved alternative to plasma for urgent warfarin reversal